NNITS-Nitazoxanide for Norovirus in Transplant Patients Study
Public ClinicalTrials.gov record NCT03395405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
Study identification
- NCT ID
- NCT03395405
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Interventions
- Nitazoxanide Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2018
- Primary completion
- Aug 23, 2021
- Completion
- Aug 23, 2021
- Last update posted
- May 20, 2025
2018 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwestern University - Comprehensive Transplant Center | Chicago | Illinois | 60611-2927 | — |
| University of Kansas Medical Center - Infectious Diseases | Kansas City | Kansas | 66160-8500 | — |
| Johns Hopkins Hospital - Medicine - Infectious Diseases | Baltimore | Maryland | 21287-0005 | — |
| University of Michigan School of Public Health - Epidemiology | Ann Arbor | Michigan | 48109-2029 | — |
| University of Michigan - Infectious Disease Clinic at Taubman Center | Ann Arbor | Michigan | 48109 | — |
| University of Nebraska Medical Center - Infectious Diseases | Omaha | Nebraska | 68198-5400 | — |
| Cincinnati Children's Hospital Medical Center Vaccine Research Center | Cincinnati | Ohio | 45229-3039 | — |
| University of Pittsburgh - Medicine - Infectious Diseases | Pittsburgh | Pennsylvania | 15213-3403 | — |
| Children's Hospital of Pittsburgh of UPMC - Pediatric Infectious Diseases | Pittsburgh | Pennsylvania | 15224-1529 | — |
| University of Texas Southwestern Medical Center - Internal Medicine Subspecialties Clinic | Dallas | Texas | 75390-8884 | — |
| Fred Hutchinson Cancer Research Center - Vaccine and Infectious Diseases | Seattle | Washington | 98109-4433 | — |
| University of Washington - Medicine | Seattle | Washington | 98195-7110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03395405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03395405 live on ClinicalTrials.gov.